Eukaryotic Translation Initiation Factor 3 Subunit D Overexpression is Associated with the Occurrence and Development of Ovarian Cancer

Overview

Journal FEBS Open Bio

Specialty Biology

Date 2017 Feb 17

PMID 28203520

Citations 7

Authors

Yaying Lin

Rongrong Zhang

Ping Zhang

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer is the most common cause of gynaecological cancer-associated death; thus, promising biomarkers and new therapeutic targets for ovarian cancer must be explored. Here, we report that eukaryotic translation initiation factor 3 subunit D (EIF3D), a member of the EIF3 family, was overexpressed in ovarian cancer clinical tissues. Furthermore, the expression of EIF3D was correlated with the International Federation of Gynecology and Obstetrics stage and pathological differentiation stage. 3-(4,5-dimethylthylthiazol-2-yl)-2 (MTT) and colony formation assays revealed that the lentivirus-mediated knockdown of EIF3D suppresses cell proliferation in the ovarian tumour cell lines CAOV-3 and SKOV-3. Flow cytometry revealed that cells were arrested at the G2/M phase of the cell cycle and that cyclin-dependent kinase 1 was also altered after EIF3D silencing. The results presented here demonstrate that EIF3D may play an important role in the occurrence and development of ovarian cancer.

Citing Articles

Exosomal insights into ovarian cancer stem cells: revealing the molecular hubs.

Sojoudi K, Solaimani M, Azizi H J Ovarian Res. 2025; 18(1):20.

PMID: 39891297 PMC: 11784003. DOI: 10.1186/s13048-025-01597-3.

Ribosomal rodeo: wrangling translational machinery in gynecologic tumors.

Filipek K, Penzo M Cancer Metastasis Rev. 2024; 44(1):13.

PMID: 39621173 PMC: 11611960. DOI: 10.1007/s10555-024-10234-2.

Deciphering EIF3D's Role in Immune Regulation and Malignant Progression: A Pan-Cancer Analysis with a Focus on Colon Adenocarcinoma.

Zhou Y, Chai R, Wang Y, Yu X J Inflamm Res. 2024; 17:6847-6862.

PMID: 39372593 PMC: 11451429. DOI: 10.2147/JIR.S469948.

Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer.

Sobocan M, Brunialti D, Sprung S, Schatz C, Knez J, Kavalar R J Ovarian Res. 2022; 15(1):73.

PMID: 35718769 PMC: 9208098. DOI: 10.1186/s13048-022-00998-y.

Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.

Yang X, Xu L, Yang Y, Xiong C, Yu J, Wang Y J Ovarian Res. 2020; 13(1):100.

PMID: 32862831 PMC: 7457759. DOI: 10.1186/s13048-020-00707-7.

References

Yoon C, Miah M, Kim K, Bae Y . New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses. EMBO Rep. 2010; 11(5):393-9. PMC: 2868534. DOI: 10.1038/embor.2010.45. View

Shi J, Kahle A, Hershey J, Honchak B, Warneke J, Leong S . Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene. 2006; 25(35):4923-36. DOI: 10.1038/sj.onc.1209495. View

Querol-Audi J, Sun C, Vogan J, Smith M, Gu Y, Cate J . Architecture of human translation initiation factor 3. Structure. 2013; 21(6):920-8. PMC: 3739965. DOI: 10.1016/j.str.2013.04.002. View

Fan Y, Guo Y . Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway. Int J Clin Exp Pathol. 2015; 8(9):10420-7. PMC: 4637565. View

Bandyopadhyay A, Lakshmanan V, Matsumoto T, Chang E, Maitra U . Moe1 and spInt6, the fission yeast homologues of mammalian translation initiation factor 3 subunits p66 (eIF3d) and p48 (eIF3e), respectively, are required for stable association of eIF3 subunits. J Biol Chem. 2001; 277(3):2360-7. DOI: 10.1074/jbc.M107790200. View

Wagner S, Herrmannova A, Malik R, Peclinovska L, Valasek L . Functional and biochemical characterization of human eukaryotic translation initiation factor 3 in living cells. Mol Cell Biol. 2014; 34(16):3041-52. PMC: 4135593. DOI: 10.1128/MCB.00663-14. View

Sudo H, Tsuji A, Sugyo A, Kohda M, Sogawa C, Yoshida C . Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. Genomics. 2010; 95(4):210-6. DOI: 10.1016/j.ygeno.2010.02.002. View

Kim H, Choi I, Kim C, Kim H, Oshima A, Michalowski A . A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS One. 2011; 6(2):e16694. PMC: 3041770. DOI: 10.1371/journal.pone.0016694. View

Li H, Zhou F, Wang H, Lin D, Chen G, Zuo X . Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest. Biotechnol Appl Biochem. 2014; 62(5):615-20. DOI: 10.1002/bab.1305. View

10.

Modelska A, Turro E, Russell R, Beaton J, Sbarrato T, Spriggs K . The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape. Cell Death Dis. 2015; 6:e1603. PMC: 4669741. DOI: 10.1038/cddis.2014.542. View

11.

Li Z, Lin S, Jiang T, Wang J, Lu H, Tang H . Overexpression of eIF3e is correlated with colon tumor development and poor prognosis. Int J Clin Exp Pathol. 2014; 7(10):6462-74. PMC: 4230162. View

12.

Jager S, Cimermancic P, Gulbahce N, Johnson J, McGovern K, Clarke S . Global landscape of HIV-human protein complexes. Nature. 2011; 481(7381):365-70. PMC: 3310911. DOI: 10.1038/nature10719. View

13.

Sun C, Todorovic A, Querol-Audi J, Bai Y, Villa N, Snyder M . Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3). Proc Natl Acad Sci U S A. 2011; 108(51):20473-8. PMC: 3251073. DOI: 10.1073/pnas.1116821108. View

14.

. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474(7353):609-15. PMC: 3163504. DOI: 10.1038/nature10166. View

15.

Lichtenberger B, Tan P, Niederleithner H, Ferrara N, Petzelbauer P, Sibilia M . Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell. 2010; 140(2):268-79. DOI: 10.1016/j.cell.2009.12.046. View

16.

Spilka R, Ernst C, Mehta A, Haybaeck J . Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett. 2013; 340(1):9-21. DOI: 10.1016/j.canlet.2013.06.019. View

17.

Yu X, Zheng B, Chai R . Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells. Biosci Rep. 2014; 34(6):e00161. PMC: 4266922. DOI: 10.1042/BSR20140078. View

18.

Santamaria D, Barriere C, Cerqueira A, Hunt S, Tardy C, Newton K . Cdk1 is sufficient to drive the mammalian cell cycle. Nature. 2007; 448(7155):811-5. DOI: 10.1038/nature06046. View

19.

Hongo F, Takaha N, Oishi M, Ueda T, Nakamura T, Naitoh Y . CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence. Urol Oncol. 2014; 32(8):1240-6. DOI: 10.1016/j.urolonc.2014.05.006. View

20.

Gao Y, Teng J, Hong Y, Qu F, Ren J, Li L . The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer. Med Oncol. 2015; 32(7):518. DOI: 10.1007/s12032-015-0518-x. View